MoneyWorks4Me

Biocon - Quaterly Results

10 Aug 2023 Evaluate
The revenue for the June 2023 quarter is pegged at Rs. 5132.00 millions, about 16.19% up against Rs. 4417.00 millions recorded during the year-ago period.Net Profit witnessed a 212.75% growth almost the double from Rs. 149.00 millions to Rs. 466.00  millions  of same quarter last year.Operating Profit saw a handsome growth to 1080.00 millions from 512.00 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 5132.00 4417.00 16.19 5132.00 4417.00 16.19 19929.00 17382.00 14.65
Other Income 360.00 486.00 -25.93 360.00 486.00 -25.93 2714.00 1872.00 44.98
PBIDT 1080.00 512.00 110.94 1080.00 512.00 110.94 2949.00 2483.00 18.77
Interest 483.00 1.00 48200.00 483.00 1.00 48200.00 696.00 4.00 17300.00
PBDT 794.00 511.00 55.38 794.00 511.00 55.38 30881.00 2479.00 1145.70
Depreciation 298.00 286.00 4.20 298.00 286.00 4.20 1169.00 1082.00 8.04
PBT 496.00 225.00 120.44 496.00 225.00 120.44 29712.00 1397.00 2026.84
TAX 30.00 76.00 -60.53 30.00 76.00 -60.53 1228.00 536.00 129.10
Deferred Tax -9.00 0.00 0.00 -9.00 0.00 0.00 0.00 0.00 0.00
PAT 466.00 149.00 212.75 466.00 149.00 212.75 28484.00 861.00 3208.25
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 21.04 11.59 81.55 21.04 11.59 81.55 14.80 14.28 3.59
Peers
Company Name CMP
Sun Pharma. Inds. 1782.85
Dr. Reddys Labs. 1196.05
Cipla 1335.60
Lupin 2010.00
Zydus Lifesciences 1142.55
View more..